APA (7th ed.) Citation

Fanijavadi, S., & Jensen, L. H. (2025). Dysbiosis–NK Cell Crosstalk in Pancreatic Cancer: Toward a Unified Biomarker Signature for Improved Clinical Outcomes. International Journal of Molecular Sciences, 26(2), 730. https://doi.org/10.3390/ijms26020730

Chicago Style (17th ed.) Citation

Fanijavadi, Sara, and Lars Henrik Jensen. "Dysbiosis–NK Cell Crosstalk in Pancreatic Cancer: Toward a Unified Biomarker Signature for Improved Clinical Outcomes." International Journal of Molecular Sciences 26, no. 2 (2025): 730. https://doi.org/10.3390/ijms26020730.

MLA (9th ed.) Citation

Fanijavadi, Sara, and Lars Henrik Jensen. "Dysbiosis–NK Cell Crosstalk in Pancreatic Cancer: Toward a Unified Biomarker Signature for Improved Clinical Outcomes." International Journal of Molecular Sciences, vol. 26, no. 2, 2025, p. 730, https://doi.org/10.3390/ijms26020730.